Brewin Dolphin Wealth Management LTD Jazz Pharmaceuticals PLC Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 250 shares of JAZZ stock, worth $27,865. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$27,865
Previous $39,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding JAZZ
# of Institutions
490Shares Held
57MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$705 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$685 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$276 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$225 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$225 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.99B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...